Targeting the Neuropeptide (NPY) Y4 receptor (Y4R) and the glucagon-like peptide 1 receptor (GLP-1R) for the treatment of Diabetes.

Project: Research

Project Details

StatusFinished
Effective start/end date1/06/2017 → 31/10/2018